Call for Papers  

Article Details


Serum IL-33 Level and IL-33, IL1RL1 Gene Polymorphisms in Asthma and Multiple Sclerosis Patients

[ Vol. 19 , Issue. 5 ]

Author(s):

Maryam Ahmadi, Farshid Fathi, Saloomeh Fouladi, Fereshteh Alsahebfosul, Mostafa Manian and Nahid Eskandari*   Pages 357 - 363 ( 7 )

Abstract:


<P>Background: Asthma is a chronic and complex inflammatory disease of the respiratory tract. Also, multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Against this background, IL-33 and IL1RL1 play a critical role in autoimmune and inflammatory disorders. Here, we explored the IL-33 serum level and two potential genetic variants in the IL33 gene and its receptor in Iranian asthma and MS patients. </P><P> Methods: This study consisted of asthma (n=140) and MS patients (n=140), and healthy subjects (n=72). Genotyping was carried out in two genetic polymorphisms, rs1342326 variant of IL-33 and rs10204137SNP variant of IL-33 receptor genes, using High- Resolution Melt Real- Time PCR based method. The level of serum IL-33 was also measured using enzyme-linked immunosorbent assay method. </P><P> Results: The level of IL33 was significantly higher in asthma and MS patients compared to the control group (P< 0.001- P<0.001).The frequency distribution of the genotype in rs1342326 variant of IL-33 gene in patients with asthma, MS and healthy subjects was not significantly different (P>0.05). The frequency distribution of the genotype in rs10204137 variant of IL-33 gene in MS patients and healthy subjects was significantly different (p = 0.013). </P><P> Conclusion: Our findings demonstrated that asthma and MS patients had a higher level of IL-33, and IL-33 receptor genetic polymorphism was associated with MS. Further studies in a larger multicenter setting are needed to explore the value of this marker as a risk stratification biomarker.</P>

Keywords:

Asthma, Multiple Sclerosis, IL-33, IL1RL1, polymorphism, IL-33 serum level.

Affiliation:

Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Department of Immunology, school of Medicine, Iran University of Medical Sciences, Tehran, Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan



Read Full-Text article